You are here
Valeant leads the way in steep price increase of skin drugs
TWO drugs sold by Valeant Pharmaceuticals International to treat cancer-related skin conditions increased in price by about 1,700 per cent over the last six years, according to a newly published survey that found big increases in the cost of dermatology drugs across the board.
- CALL +65 6388 3838
- EMAIL firstname.lastname@example.org